148 related articles for article (PubMed ID: 1124148)
1. [Trial treatment of diabetic retinopathy by inhibition of pituitary somatotropin secretion with MAP].
Bruni B; Bruni-Bocher K; Della Valle A; Gamba S
Minerva Med; 1975 Mar; 66(21):1001-23. PubMed ID: 1124148
[TBL] [Abstract][Full Text] [Related]
2. Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation.
Wright AD; Kohner EM; Oakley NW; Hartog M; Joplin GF; Fraser TR
Br Med J; 1969 May; 2(5653):346-8. PubMed ID: 5768460
[TBL] [Abstract][Full Text] [Related]
3. Interstitial gamma irradiation by 198Au of the pituitary in diabetic retinopathy. Selective growth hormone blockade and ocular results.
Schaub C; Szikla G; Drouin P; Bleut-Pajot MT; Mejean L; Debry G; Talairach J
J Neurosurg; 1977 Jun; 46(6):703-16. PubMed ID: 323427
[TBL] [Abstract][Full Text] [Related]
4. [Secretion of GH and diabetic retinopathy].
Greco AV; Ricci B; Ghirlanda G; Fedeli G; Altomonte L; Rebuzzi A
Minerva Med; 1976 Sep; 67(45):2902-18. PubMed ID: 967359
[TBL] [Abstract][Full Text] [Related]
5. Hypophysectomy in diabetic retinopathy. The relationship between the degree of pituitary ablation and ocular response.
Adams DA; Rand RW; Roth NH; Dashe AM; Gipstein RM; Heuser G
Diabetes; 1974 Aug; 23(8):698-707. PubMed ID: 4604549
[No Abstract] [Full Text] [Related]
6. Computer analysis of ocular results following selective blockade of growth-hormone in diabetic retinopathy. A collaborative study.
Schaub C; Boujard O; Brouard N; Drouin P; Le Devehat C; Lemoine A; Mejean L; Mounier F; Regnault F; Saudax A
Metab Ophthalmol; 1984-1985; 8(1):35-42. PubMed ID: 6394947
[TBL] [Abstract][Full Text] [Related]
7. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy.
Brinchmann-Hansen O; Dahl-Jørgensen K; Hanssen KF; Sandvik L
Arch Ophthalmol; 1988 Sep; 106(9):1242-6. PubMed ID: 3046587
[TBL] [Abstract][Full Text] [Related]
8. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
9. [Effect of medroxyprogesterone on plasma somatotropin (GH) levels in 14 patients with acromegaly].
Tourniaire J; Pousset G
Ann Endocrinol (Paris); 1973; 34(2):222-4. PubMed ID: 4745280
[TBL] [Abstract][Full Text] [Related]
10. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of pituitary deficiency by hypoglycemia-induced growth hormone secretion in hypophysectomized diabetics].
Teuscher A; Escher F; Zahnd G
Schweiz Med Wochenschr; 1969 Jul; 99(31):1110-4. PubMed ID: 5406976
[No Abstract] [Full Text] [Related]
12. Grwoth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate.
Concannon P; Altszuler N; Hampshire J; Butler WR; Hansel W
Endocrinology; 1980 Apr; 106(4):1173-7. PubMed ID: 6444575
[TBL] [Abstract][Full Text] [Related]
13. [Somatotropic hormone, diabetes and diabetic angiopathy].
Dobrev DG
Vutr Boles; 1979; 18(5):21-7. PubMed ID: 390884
[No Abstract] [Full Text] [Related]
14. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
Adank C; Koerner F
Ophthalmologica; 1985; 190(2):102-11. PubMed ID: 3982791
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of diabetic retinopathy with somatostatin analogues].
Lang GE
Ophthalmologe; 2004 Mar; 101(3):290-3. PubMed ID: 15007609
[TBL] [Abstract][Full Text] [Related]
16. [Ophthalmologic indications and results of stereo-GIHF in diabetic retinopathy. 2].
Debry G; Schaub C; Drouin P; Szikla ; Saudax E; Boujard O; Talairach J
Neurochirurgie; 1977 Jul; 23(2):97-109. PubMed ID: 562480
[No Abstract] [Full Text] [Related]
17. Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
Kohner EM; Stratton IM; Aldington SJ; Turner RC; Matthews DR
Diabetologia; 1999 Sep; 42(9):1107-12. PubMed ID: 10447523
[TBL] [Abstract][Full Text] [Related]
18. Types of diabetic retinopathy and treatment.
Hollows FC; Beaumont P
Trans Ophthalmol Soc N Z; 1973; 25():50-5. PubMed ID: 4519230
[TBL] [Abstract][Full Text] [Related]
19. Diabetic retinopathy: different risk factors for exudates and haemorrhages.
Dowd TC; Howard-Williams J; Thursfield V; Bron AJ; Hockaday TD; Mann JI
Int Ophthalmol; 1986 Apr; 9(1):11-5. PubMed ID: 3721707
[TBL] [Abstract][Full Text] [Related]
20. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
